Low-Risk MDS: Can We Prevent Progression?

Описание к видео Low-Risk MDS: Can We Prevent Progression?

Dr. Casey O’Connell, University of Southern California, Keck School of Medicine, will provide an overview summarizing changes in the treatment landscape for patients with low-risk myelodysplastic syndromes including updates from the 2020 EHA Congress. The concerns of low-risk MDS patients and their caregivers will be addressed.

Комментарии

Информация по комментариям в разработке